[ Cancer Research Institute - STAR Program | Research Funding ]
Event details
| Date | 15.01.2021 |
| Category | Call for proposal |
Aim: The CRI Lloyd J. Old STAR Program—Scientists Taking Risks—provides long-term funding to mid-career scientists, giving them the freedom and flexibility to pursue high-risk, high-reward research at the forefront of discovery and innovation in cancer immunotherapy. These grants are not tied to a specific research project, but rather support outstanding researchers based on the quality and promise of their overall work.
The profile of a recipient investigator would be a scientist who takes risks with the expectation of high rewards, even in the face of potential failure. They will use their expertise, scientific acumen, and visionary curiosity to ask important, significant, and often non-obvious immunological questions. It is expected that their discoveries in basic or translational research will ultimately influence the development of new immune-based therapies that will be effective for more cancer patients.
Duration: 60 months
Funding: USD $1’250’000
Eligibility: The applicant must have an M.D., Ph.D., or M.D./Ph.D. (or equivalent). Applicants must belong to one of the following categories as of July 1, 2021:
Applicants are expected to commit a minimum of 80% of their time to conducting research. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad.
How to Apply: The process for applying for a Lloyd J. Old STAR Program grant consists of two parts: an application, and an (invited) interview in New York City. The deadline for the receipt of applications is January 15; application forms can be submitted on the online platform. EPFL applicants should contact the Research Office as soon as you begin your application to arrange for the Administrative Certification signature. Candidates will be notified in early March whether or not they have been invited to the Cancer Research Institute in New York City for an interview.
Deadline: 15 January 2021
Further information
The profile of a recipient investigator would be a scientist who takes risks with the expectation of high rewards, even in the face of potential failure. They will use their expertise, scientific acumen, and visionary curiosity to ask important, significant, and often non-obvious immunological questions. It is expected that their discoveries in basic or translational research will ultimately influence the development of new immune-based therapies that will be effective for more cancer patients.
Duration: 60 months
Funding: USD $1’250’000
Eligibility: The applicant must have an M.D., Ph.D., or M.D./Ph.D. (or equivalent). Applicants must belong to one of the following categories as of July 1, 2021:
- Tenure-track assistant professor with a minimum of 3 years in this position (appointed on or before July 1, 2018)
- Tenure-track associate professor with a maximum of 3 years in this position (appointed on or after July 1, 2018)
Applicants are expected to commit a minimum of 80% of their time to conducting research. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad.
How to Apply: The process for applying for a Lloyd J. Old STAR Program grant consists of two parts: an application, and an (invited) interview in New York City. The deadline for the receipt of applications is January 15; application forms can be submitted on the online platform. EPFL applicants should contact the Research Office as soon as you begin your application to arrange for the Administrative Certification signature. Candidates will be notified in early March whether or not they have been invited to the Cancer Research Institute in New York City for an interview.
Deadline: 15 January 2021
Further information
- More information about the program is available here.
- The application guidelines can be found here.
- The application form can be found here.
- The application portal can be found here.
- For the institutional signature, or for any other questions, please contact the Research Office.
Practical information
- General public
- Free